Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
24
datasets available to search
ShareScore release 0.9.0
Dataset results
24 results for “cost utility analysis”
In-hospital patient safety events, healthcare costs and utilization: an analysis of data from the incident reporting system in an academic medical center
<p>Raw Datasets for the study 'In-hospital patient safety events, healthcare costs and utilization: an analysis of data from the incident reporting system in an academic medical center'.</p>
A Cost-Utility Analysis of Oral Triptans for Migraine in an Adult Outpatient Setting in Japan
<p><strong><span>Objectives</span></strong><span><strong>. </strong>Pharmacoeconomic studies have not been performed frequently in Japan. This study attempted to clarify which oral triptans, including eletriptan, naratriptan, rizatriptan, sumatriptan, and zolmitrian, are cost-effective in treating migraine in an adult outpatient setting in Japan.</span></p> <p><strong><span>Methods</span></strong><span><strong>. </strong>A cost-utility analysis was conducted for healthcare payers. The population targeted was Japanese patients over the age of 18 who experienced migraines. A base-case model was prepared using probabilities from a network meta-analysis. Direct costs consisted of medical and drug costs (2017 version). Effectiveness was measured with the EQ-5D-3L questionnaire for adult patients with migraine. The duration of the study was 30 days.</span></p> <p><strong><span>Results</span></strong><span><strong>.</strong> The cost-utility analysis base-case scenario demonstrated that eletriptan, rizatriptan, and sumatriptan were cost-effective from the healthcare payers' perspective. Deterministic sensitivity analyses showed that the results were sensitive to the drug prices of three triptans. A probabilistic sensitivity analysis revealed that eletriptan, rizatriptan, and sumatriptan were acceptable because of their accessibility and the healthcare payer's willingness to pay for them (5,000,000 yen/quality-adjusted life-years) were 0.662, 0.172, and 0.075, respectively.</span></p> <p><strong><span>Conclusions</span><span>.</span> </strong><span>The results revealed that eletriptan, rizatriptan, and sumatriptan are cost-effective treat</span><span>ments</span><span> in Japan </span><span>for </span><span>migraine from a healthcare payer's perspective.</span></p>
Cost Utility Analysis of HD and CAPD in Ministry of Health Dialysis Centres, Malaysia
ClinicalTrials.gov study NCT02862717. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Transcranial Direct Current Stimulation (tDCS) Cost-utility-analysis in Medical Care on Depressive Episode With One Drug Therapy Failure.
ClinicalTrials.gov study NCT03758105. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass
ClinicalTrials.gov study NCT02972684. IPD Sharing: NO. Countries: 1. Publications: 2.
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00364663. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Cost-utility Analysis of Maintenance rTMS for Treatment-resistant Depression
ClinicalTrials.gov study NCT03701724. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Tibial nerve decompression for the prevention of the diabetic foot: a cost-utility analysis using Markov model simulations.
Open the record for dataset details and reuse information.
Cost-utility Analysis of the Outpatient Versus Conventional Hospitalization in Treatment of Occlusive Arterial Disease
ClinicalTrials.gov study NCT02581150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost Utility Analysis in Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00813254. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost-utility Analysis of Ambulatory Care Compared to Conventional Patient Care of Permanent Pacemakers Replacement for Elective Replacement Indicator
ClinicalTrials.gov study NCT03876600. IPD Sharing: NO. Countries: 1. Publications: 0.
Cost-utility Analysis of the Use of the Paro Robotic Seal by Elderly Patients With Moderate or Severe Cognitive Disorders in Institutions: a Randomised Study.
ClinicalTrials.gov study NCT04941222. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of Aortic Stenosis in Brazil: Cost-Utility Analysis of TAVI vs SAVR
ClinicalTrials.gov study NCT04067089. IPD Sharing: YES. Countries: 1. Publications: 0.
Cost-Utility Analysis Hospital Versus Home in Multiple Myeloma
ClinicalTrials.gov study NCT03493737. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cost-utility Analysis of Fenestrated Aortic Stents Versus Open Surgery for the Treatment of Complex Abdominal Aortic Aneurysms
ClinicalTrials.gov study NCT04671732. IPD Sharing: NO. Countries: 1. Publications: 0.
Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients
ClinicalTrials.gov study NCT01049711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost-utility Analysis Treatment of Bartholin's Abscess : Word Catheter Versus Incision-drainage.
ClinicalTrials.gov study NCT04093310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost-utility Analysis of the AlloMap® Test
ClinicalTrials.gov study NCT02602691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost-utility Analysis, Cost-effectiveness Analysis, Budget Impact Analysis
ClinicalTrials.gov study NCT04283565. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.
ClinicalTrials.gov study NCT06846905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.